MRI Assessment of Myocardial Deformation for Risk Stratification of Major Arrhythmic Events in Patients With Non-Ischemic Cardiomyopathy Eligible for Primary Prevention Implantable Cardioverter Defibrillators.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9105850 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-2586 (Electronic) Linking ISSN: 10531807 NLM ISO Abbreviation: J Magn Reson Imaging Subsets: MEDLINE
    • Publication Information:
      Publication: <2005-> : Hoboken , N.J. : Wiley-Liss
      Original Publication: Chicago, IL : Society for Magnetic Resonance Imaging, c1991-
    • Subject Terms:
    • Abstract:
      Background: Implantable cardioverter-defibrillator (ICD) intervention is an established prophylactic measure. Identifying high-benefit patients poses challenges.
      Purpose: To assess the prognostic value of cardiac magnetic resonance imaging (MRI) parameters including myocardial deformation for risk stratification of ICD intervention in non-ischemic cardiomyopathy (NICM) while accounting for competing mortality risk.
      Study Type: Retrospective and prospective.
      Population: One hundred and fifty-nine NICM patients eligible for primary ICD (117 male, 54 ± 13 years) and 49 control subjects (38 male, 53 ± 5 years).
      Field Strength/sequence: Balanced steady state free precession (bSSFP) and three-dimensional phase-sensitive inversion-recovery late gadolinium enhancement (LGE) sequences at 1.5 T or 3 T.
      Assessment: Patients underwent MRI before ICD implantation and were followed up. Functional parameters, left ventricular global radial, circumferential and longitudinal strain, right ventricular free wall longitudinal strain (RV FWLS) and left atrial strain were measured (Circle, cvi42). LGE presence was assessed visually. The primary endpoint was appropriate ICD intervention. Models were developed to determine outcome, with and without accounting for competing risk (non-sudden cardiac death), and compared to a baseline model including LGE and clinical features.
      Statistical Tests: Wilcoxon non-parametric test, Cox's proportional hazards regression, Fine-Gray competing risk model, and cumulative incidence functions. Harrell's c statistic was used for model selection. A P value <0.05 was considered statistically significant.
      Results: Follow-up duration was 1176 ± 960 days (median: 896). Twenty-six patients (16%) met the primary endpoint. RV FWLS demonstrated a significant difference between patients with and without events (-12.5% ± 5 vs. -16.4% ± 5.5). Univariable analyses showed LGE and RV FWLS were significantly associated with outcome (LGE: hazard ratio [HR] = 3.69, 95% CI = 1.28-10.62; RV FWLS: HR = 2.04, 95% CI = 1.30-3.22). RV FWLS significantly improved the prognostic value of baseline model and remained significant in multivariable analysis, accounting for competing risk (HR = 1.73, 95% CI = 1.12-2.66).
      Data Conclusions: In NICM, RV FWLS may provide additional predictive value for predicting appropriate ICD intervention.
      Level of Evidence: 2 TECHNICAL EFFICACY: Stage 5.
      (© 2024 International Society for Magnetic Resonance in Medicine.)
    • References:
      JACC Cardiovasc Imaging. 2018 Sep;11(9):1274-1284. (PMID: 29680351)
      N Engl J Med. 2012 Dec 13;367(24):2275-83. (PMID: 23131066)
      Circulation. 2016 Feb 9;133(6):601-9. (PMID: 26858290)
      Radiology. 2023 May;307(3):e222239. (PMID: 36943075)
      JACC Cardiovasc Imaging. 2016 Sep;9(9):1046-1055. (PMID: 27450871)
      Circulation. 2014 Jan 28;129(4):516-26. (PMID: 24470473)
      JACC Cardiovasc Imaging. 2018 Oct;11(10):1419-1429. (PMID: 29361479)
      Circ Arrhythm Electrophysiol. 2017 Jan;10(1):. (PMID: 28087564)
      J Am Coll Cardiol. 2003 May 21;41(10):1707-12. (PMID: 12767651)
      Radiology. 2021 Nov;301(2):322-329. (PMID: 34402663)
      Circulation. 2017 Jul 11;136(2):215-231. (PMID: 28696268)
      Circulation. 2013 Sep 10;128(11 Suppl 1):S14-23. (PMID: 24030398)
      Circulation. 2013 Oct 8;128(15):1623-33. (PMID: 23965488)
      Circ Arrhythm Electrophysiol. 2019 Mar;12(3):e007022. (PMID: 30866666)
      J Am Soc Echocardiogr. 2019 Jul;32(7):836-844.e1. (PMID: 30979539)
      J Am Coll Cardiol. 2018 Oct 2;72(14):1677-1749. (PMID: 29097294)
      J Magn Reson Imaging. 2017 Nov;46(5):1263-1280. (PMID: 28471530)
      Circ Arrhythm Electrophysiol. 2018 Jun;11(6):e006091. (PMID: 29769224)
      JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1180-1193. (PMID: 28982571)
      J Cardiovasc Magn Reson. 2019 May 16;21(1):28. (PMID: 31096987)
      JACC Cardiovasc Imaging. 2022 Jun;15(6):1015-1026. (PMID: 35680209)
      Heart Rhythm. 2016 Feb;13(2):490-7. (PMID: 26409099)
      Circ Cardiovasc Imaging. 2014 Mar;7(2):250-258. (PMID: 24363358)
      N Engl J Med. 2004 May 20;350(21):2140-50. (PMID: 15152059)
      Radiology. 1982 Apr;143(1):29-36. (PMID: 7063747)
      Circulation. 2002 Mar 26;105(12):1453-8. (PMID: 11914254)
      Circ Heart Fail. 2015 Sep;8(5):927-37. (PMID: 26224792)
      J Am Coll Cardiol. 2022 Feb 22;79(7):665-678. (PMID: 35177196)
      J Cardiovasc Magn Reson. 2017 Oct 23;19(1):79. (PMID: 29058590)
      J Am Coll Cardiol. 2019 Apr 2;73(12):1463-1482. (PMID: 30922478)
      N Engl J Med. 2004 May 20;350(21):2151-8. (PMID: 15152060)
      JACC Cardiovasc Imaging. 2013 Aug;6(8):851-60. (PMID: 23850252)
      N Engl J Med. 2016 Sep 29;375(13):1221-30. (PMID: 27571011)
      JAMA. 2013 Mar 6;309(9):896-908. (PMID: 23462786)
      Eur Heart J Cardiovasc Imaging. 2018 Jul 1;19(7):800-807. (PMID: 28977357)
      Int J Cardiovasc Imaging. 2022 Apr;38(4):863-872. (PMID: 34839396)
    • Grant Information:
      R01AG068141 United States GF NIH HHS; 1R01HL129185 United States GF NIH HHS; R01HL161697 United States GF NIH HHS; R01 HL161697 United States HL NHLBI NIH HHS; R01 AG068141 United States AG NIA NIH HHS; R21 HL127650 United States HL NHLBI NIH HHS; R01 HL129157 United States HL NHLBI NIH HHS; R01 HL129185 United States HL NHLBI NIH HHS; R01 HL127015 United States HL NHLBI NIH HHS; 1R01HL127015 United States GF NIH HHS; 1R01HL129157 United States GF NIH HHS
    • Contributed Indexing:
      Keywords: appropriate ICD intervention; myocardial strain; non‐ischemic cardiomyopathy; risk stratification of major arrhythmic events
    • Accession Number:
      AU0V1LM3JT (Gadolinium)
    • Publication Date:
      Date Created: 20240119 Date Completed: 20241010 Latest Revision: 20241012
    • Publication Date:
      20241012
    • Accession Number:
      PMC11258208
    • Accession Number:
      10.1002/jmri.29238
    • Accession Number:
      38240166